Home
News
- 1 MRNA stock price increased by 4.83% over the past week and the current price is below a crucial trendline.
- 2 Moderna Inc. (NASDAQ: MRNA) stock’s 52-week price range is $95 – $217.
Moderna Inc. (MRNA) stock market capitalization is $42.935 Billion and the total shares float is $330.891 Million. Moreover, the stock’s basic EPS is $3.06 and the price-to-earnings ratio is 339.90. Moderna Inc. (MRNA) experienced an incline in its earnings at a rate of 60.4% per year on average, according to Simply Wall St., a financial website. The biotech industry’s average annual earnings growth is 22.7%. Therefore, MRNA earnings are higher than the industry average.
Moreover, Moderna Inc. (MRNA) stock performed well in the last month, increasing 14.26% and plummeting by 25.74% in the last six months. Moderna Inc. (NASDAQ: MRNA) stock has a negative year-to-date return of 37.62% and a one-year return of 15.82%.
The average volume is 5.513 Million and the current volume is 4.094 Million where the current volume is above the 10-day aggregate volume.
The top shareholder of the company is Baillie Gifford & Co. owns 12.01% with a share count of 45,711,095 which holds it’s current value of 5.0 Billion.
Technical Analysis of MRNA Stock Price in 1-D Timeframe
The price action shows that Moderna Inc. (NASDAQ: MRNA) stock price took rejection from its peak at around $212 and has been on a plummeting trend since December 2022, decreasing by making higher highs and higher lows.
At the time of writing, MRNA stock is trading at around $112 and facing resistance from the crucial trendline resistance. If it is breached, then one may see a major trend change above the previous swing around $127 and if MRNA fails to cross the trendline, the trend will continue its usual downtrend.
Therefore, if the MRNA price fails to sustain the current level and drops, then technically on the charts, it might hit the nearest support levels of $103 and $95.
However, if it maintains the current level and succeeds in its attempt to breach the trendline, then MRNA prices could continue to move upward and reach the first and second technical resistances of $117 and $127.
At the time of publishing, Moderna Inc. (NASDAQ: MRNA) is trading between the major 20 and 50-day EMA (exponential moving averages).
The MACD line at 0.7977 and signal line at 0.9243 are below the zero line and both lines have crossed each other but the histogram gap is lean.
The current value of RSI is 54.11 points. The 14 SMA is below the median line at 48.93 points which indicates that the stock is neutral.
Collectively, all indicators indicate uncertainty and neutrality as the stock is at a crucial level and the activity on both sides is strong. From the trendline, the stock can either go up or continue falling.
Summary
Moderna Inc. (NASDAQ: MRNA) chart indicates that the traders and investors of the stock price are uncertain on the 1-D time frame. The price action shows possible outlooks of both sides at the time of publishing. The technical analysis tools of the Moderna stock price are neutral.
Technical Levels
- Support levels: $103 and $95
- Resistance levels: $117 and $127
Disclaimer
In this article, the views and opinions stated by the author, or any people named are for informational purposes only, and they don’t establish the investment, financial, or any other advice. Trading or investing in cryptocurrency assets comes with a risk of financial loss.
Steve Anderson is an Australian crypto enthusiast. He is a specialist in management and trading for over 5 years. Steve has worked as a crypto trader, he loves learning about decentralisation, understanding the true potential of the blockchain.
